Nature of the Event

Rose Merc Limited has made a regulatory disclosure regarding the allotment of equity shares pursuant to the exercise of employee stock options under two employee stock option plans.

Key Quantitative Figures

  • Total shares allotted: 80,000 equity shares of ₹10 each fully paid-up
  • Breakdown by plan:
  • RML Employee Stock Option Plan II – 2023: 20,000 shares
  • RML Employee Stock Option Plan – 2024: 60,000 shares
  • Exercise price: ₹50 per share for both plans
  • Premium per share: ₹40 per share for both plans
  • Money realized from exercise:
  • Plan II 2023: ₹10,00,000 (from 20,000 options)
  • Plan 2024: ₹30,00,000 (from 60,000 options)
  • Total proceeds: ₹40,00,000
  • Capital structure impact:
  • Post-allotment paid-up equity share capital: ₹7,96,60,470
  • Post-allotment total number of equity shares: 79,66,047

Dates of Action

  • Committee meeting date: October 19, 2026
  • Date of share issue: October 19, 2026
  • Original scheme filing dates:
  • RML ESOP II 2023: August 11, 2023
  • RML ESOP 2024: November 26, 2024

Parties Involved

  • Regulatory bodies: BSE Limited, SEBI
  • Company representatives:
  • Vaishali Parkar Kumar, Managing Director (DIN: 09159108)
  • Dharini Kadakia, Company Secretary (Membership No: A76992)
  • Beneficiaries: Eligible employees (5 total across both plans)

Share Details

  • Face value: ₹10 per share
  • Distinctive numbers:
  • Plan II 2023: 7886048 to 7906047
  • Plan 2024: 7906048 to 7966047
  • Ranking: The new shares rank pari-passu with existing equity shares in all respects
  • Lock-in: No lock-in period applicable

Scheme Details

Both ESOP schemes are administered by the Compensation Committee and include standard terms for handling options in cases of death, permanent incapacity, resignation, termination, retirement, and corporate actions. The schemes provide for vesting after 1 year from grant date and an exercise period of 4 years from vesting.

Financial Impact

The exercise of options has resulted in a cash inflow of ₹40,00,000 to the company and increased the equity share capital by 80,000 shares, representing approximately 1.01% dilution of the pre-allotment capital.